JP2009517051A5

JP2009517051A5 -

Download PDF

Info

Publication number: JP2009517051A5
Authority: JP; Japan
Prior art keywords: actriia; bone; activin; polypeptide; protein
Prior art date: 2006-11-22
Legal status : Granted

Application number

JP2008542460A

Other languages

English (en)

Japanese (ja)

Other versions

JP2009517051A (ja

JP5261187B2 (ja

Filing date

2006-11-22

Publication date

2010-01-21

2006-11-22 Application filed filed Critical

2006-11-22 Priority claimed from PCT/US2006/045322 external-priority patent/WO2007062188A2/en

2009-04-30 Publication of JP2009517051A publication Critical patent/JP2009517051A/ja

2010-01-21 Publication of JP2009517051A5 publication Critical patent/JP2009517051A5/ja

2013-08-14 Application granted granted Critical

2013-08-14 Publication of JP5261187B2 publication Critical patent/JP5261187B2/ja

Status Active legal-status Critical Current

2026-11-22 Anticipated expiration legal-status Critical

Links

229920001184 polypeptide Polymers 0.000 description 222
210000000988 Bone and Bones Anatomy 0.000 description 140
239000000488 activin Substances 0.000 description 89
108010059616 Activins Proteins 0.000 description 85
102100008240 INHBE Human genes 0.000 description 82
210000004027 cells Anatomy 0.000 description 80
102000004169 proteins and genes Human genes 0.000 description 75
108090000623 proteins and genes Proteins 0.000 description 75
235000018102 proteins Nutrition 0.000 description 74
150000001875 compounds Chemical class 0.000 description 56
230000003042 antagnostic Effects 0.000 description 54
230000000694 effects Effects 0.000 description 53
239000005557 antagonist Substances 0.000 description 51
102000004965 antibodies Human genes 0.000 description 49
108090001123 antibodies Proteins 0.000 description 49
108020004707 nucleic acids Proteins 0.000 description 47
230000027455 binding Effects 0.000 description 46
239000000203 mixture Substances 0.000 description 46
150000007523 nucleic acids Chemical class 0.000 description 46
230000037182 bone density Effects 0.000 description 43
230000014509 gene expression Effects 0.000 description 43
230000012010 growth Effects 0.000 description 38
208000001132 Osteoporosis Diseases 0.000 description 36
239000003814 drug Substances 0.000 description 36
238000000034 method Methods 0.000 description 30
206010017076 Fracture Diseases 0.000 description 29
102000016970 Follistatin Human genes 0.000 description 27
108010014612 Follistatin Proteins 0.000 description 27
235000001014 amino acid Nutrition 0.000 description 26
206010065687 Bone loss Diseases 0.000 description 25
238000004166 bioassay Methods 0.000 description 25
229940079593 drugs Drugs 0.000 description 25
230000001965 increased Effects 0.000 description 25
108020001507 fusion proteins Proteins 0.000 description 24
102000037240 fusion proteins Human genes 0.000 description 24
150000001413 amino acids Chemical class 0.000 description 23
125000003275 alpha amino acid group Chemical group 0.000 description 21
229920001850 Nucleic acid sequence Polymers 0.000 description 20
230000015572 biosynthetic process Effects 0.000 description 20
229920003013 deoxyribonucleic acid Polymers 0.000 description 19
230000004927 fusion Effects 0.000 description 19
239000003795 chemical substances by application Substances 0.000 description 18
230000004048 modification Effects 0.000 description 18
238000006011 modification reaction Methods 0.000 description 18
238000005755 formation reaction Methods 0.000 description 17
230000003899 glycosylation Effects 0.000 description 17
238000006206 glycosylation reaction Methods 0.000 description 17
-1 Nodal Proteins 0.000 description 16
230000011664 signaling Effects 0.000 description 16
102100003272 GDF11 Human genes 0.000 description 15
101700065866 GDF11 Proteins 0.000 description 15
102100019916 MSTN Human genes 0.000 description 15
239000002773 nucleotide Substances 0.000 description 15
125000003729 nucleotide group Chemical group 0.000 description 15
230000001225 therapeutic Effects 0.000 description 15
238000004458 analytical method Methods 0.000 description 14
239000000427 antigen Substances 0.000 description 14
102000038129 antigens Human genes 0.000 description 14
108091007172 antigens Proteins 0.000 description 14
239000003446 ligand Substances 0.000 description 14
230000035772 mutation Effects 0.000 description 14
102000005962 receptors Human genes 0.000 description 14
108020003175 receptors Proteins 0.000 description 14
210000001519 tissues Anatomy 0.000 description 14
229920000160 (ribonucleotides)n+m Polymers 0.000 description 13
201000010099 disease Diseases 0.000 description 13
229910052500 inorganic mineral Inorganic materials 0.000 description 13
239000011707 mineral Substances 0.000 description 13
235000010755 mineral Nutrition 0.000 description 13
238000000746 purification Methods 0.000 description 13
230000036499 Half live Effects 0.000 description 12
108010023082 activin A Proteins 0.000 description 12
230000002401 inhibitory effect Effects 0.000 description 12
108010045030 monoclonal antibodies Proteins 0.000 description 12
102000005614 monoclonal antibodies Human genes 0.000 description 12
229920000023 polynucleotide Polymers 0.000 description 12
239000002157 polynucleotide Substances 0.000 description 12
230000035876 healing Effects 0.000 description 11
210000000963 osteoblast Anatomy 0.000 description 11
230000000790 osteoblast Effects 0.000 description 11
241000282412 Homo Species 0.000 description 10
210000004408 Hybridomas Anatomy 0.000 description 10
101710038893 MSTN Proteins 0.000 description 10
206010041569 Spinal fracture Diseases 0.000 description 10
229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 10
230000033558 biomineral tissue development Effects 0.000 description 10
230000001054 cortical Effects 0.000 description 10
238000001514 detection method Methods 0.000 description 10
238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
239000011159 matrix material Substances 0.000 description 10
229960000060 monoclonal antibodies Drugs 0.000 description 10
230000011164 ossification Effects 0.000 description 10
210000000845 Cartilage Anatomy 0.000 description 9
102000004190 Enzymes Human genes 0.000 description 9
108090000790 Enzymes Proteins 0.000 description 9
206010027452 Metastases to bone Diseases 0.000 description 9
230000002354 daily Effects 0.000 description 9
210000003527 eukaryotic cell Anatomy 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
230000001177 retroviral Effects 0.000 description 9
206010020649 Hyperkeratosis Diseases 0.000 description 8
230000037118 bone strength Effects 0.000 description 8
238000004587 chromatography analysis Methods 0.000 description 8
230000000295 complement Effects 0.000 description 8
239000000262 estrogen Substances 0.000 description 8
230000003993 interaction Effects 0.000 description 8
239000002502 liposome Substances 0.000 description 8
230000001404 mediated Effects 0.000 description 8
230000000051 modifying Effects 0.000 description 8
238000002703 mutagenesis Methods 0.000 description 8
231100000350 mutagenesis Toxicity 0.000 description 8
230000002265 prevention Effects 0.000 description 8
210000004369 Blood Anatomy 0.000 description 7
208000006386 Bone Resorption Diseases 0.000 description 7
229960004015 Calcitonin Drugs 0.000 description 7
108060001064 Calcitonin Proteins 0.000 description 7
102400000113 Calcitonin Human genes 0.000 description 7
229940088598 Enzyme Drugs 0.000 description 7
206010027476 Metastasis Diseases 0.000 description 7
239000004473 Threonine Substances 0.000 description 7
239000008280 blood Substances 0.000 description 7
230000010072 bone remodeling Effects 0.000 description 7
230000024279 bone resorption Effects 0.000 description 7
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 7
201000011510 cancer Diseases 0.000 description 7
230000002708 enhancing Effects 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
239000002609 media Substances 0.000 description 7
230000002188 osteogenic Effects 0.000 description 7
OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 7
239000002904 solvent Substances 0.000 description 7
238000006467 substitution reaction Methods 0.000 description 7
238000001356 surgical procedure Methods 0.000 description 7
229940062527 Alendronate Drugs 0.000 description 6
OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
102000008186 Collagen Human genes 0.000 description 6
MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 6
108010070675 Glutathione Transferase family Proteins 0.000 description 6
102100020039 HPGDS Human genes 0.000 description 6
229940088597 Hormone Drugs 0.000 description 6
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
241000124008 Mammalia Species 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
210000003205 Muscles Anatomy 0.000 description 6
108090000445 Parathyroid hormone Proteins 0.000 description 6
102000003982 Parathyroid hormone Human genes 0.000 description 6
240000004808 Saccharomyces cerevisiae Species 0.000 description 6
229920002684 Sepharose Polymers 0.000 description 6
102000003978 Tissue plasminogen activator Human genes 0.000 description 6
108090000373 Tissue plasminogen activator Proteins 0.000 description 6
102000004887 Transforming Growth Factor beta Human genes 0.000 description 6
108090001012 Transforming Growth Factor beta Proteins 0.000 description 6
230000018678 bone mineralization Effects 0.000 description 6
230000002308 calcification Effects 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
229960005188 collagen Drugs 0.000 description 6
230000004821 effect on bone Effects 0.000 description 6
239000005556 hormone Substances 0.000 description 6
230000001976 improved Effects 0.000 description 6
239000003112 inhibitor Substances 0.000 description 6
229960001319 parathyroid hormone Drugs 0.000 description 6
239000000199 parathyroid hormone Substances 0.000 description 6
239000006187 pill Substances 0.000 description 6
210000001236 prokaryotic cell Anatomy 0.000 description 6
230000001737 promoting Effects 0.000 description 6
238000000159 protein binding assay Methods 0.000 description 6
238000011002 quantification Methods 0.000 description 6
238000001542 size-exclusion chromatography Methods 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
239000000725 suspension Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
229960000187 tissue plasminogen activator Drugs 0.000 description 6
210000000689 upper leg Anatomy 0.000 description 6
230000003442 weekly Effects 0.000 description 6
101710024843 ACVR2B Proteins 0.000 description 5
229920001405 Coding region Polymers 0.000 description 5
230000036947 Dissociation constant Effects 0.000 description 5
241000238631 Hexapoda Species 0.000 description 5
229940015872 Ibandronate Drugs 0.000 description 5
108010056852 Myostatin Proteins 0.000 description 5
210000002997 Osteoclasts Anatomy 0.000 description 5
206010060862 Prostate cancer Diseases 0.000 description 5
GZUITABIAKMVPG-UHFFFAOYSA-N Raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 5
229960004622 Raloxifene Drugs 0.000 description 5
241000700159 Rattus Species 0.000 description 5
229940089617 Risedronate Drugs 0.000 description 5
IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 5
230000037165 Serum Concentration Effects 0.000 description 5
ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
241000700605 Viruses Species 0.000 description 5
238000010521 absorption reaction Methods 0.000 description 5
230000000692 anti-sense Effects 0.000 description 5
MPBVHIBUJCELCL-UHFFFAOYSA-N bondronat Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 description 5
230000001086 cytosolic Effects 0.000 description 5
125000001183 hydrocarbyl group Chemical group 0.000 description 5
230000002163 immunogen Effects 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
108020001756 ligand binding domains Proteins 0.000 description 5
150000002632 lipids Chemical group 0.000 description 5
230000002148 osteoclast Effects 0.000 description 5
239000008194 pharmaceutical composition Substances 0.000 description 5
229920001223 polyethylene glycol Polymers 0.000 description 5
230000002829 reduced Effects 0.000 description 5
230000001105 regulatory Effects 0.000 description 5
230000004044 response Effects 0.000 description 5
229960000759 risedronic acid Drugs 0.000 description 5
239000000126 substance Substances 0.000 description 5
HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
229940112871 Bisphosphonate drugs affecting bone structure and mineralization Drugs 0.000 description 4
229960005069 Calcium Drugs 0.000 description 4
241000699802 Cricetulus griseus Species 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
229940028334 Follicle Stimulating Hormone Drugs 0.000 description 4
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 4
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 4
206010020100 Hip fracture Diseases 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
101710040922 Os08g0547100 Proteins 0.000 description 4
208000001685 Postmenopausal Osteoporosis Diseases 0.000 description 4
230000025458 RNA interference Effects 0.000 description 4
101710023380 S100A8 Proteins 0.000 description 4
102100017875 S100A8 Human genes 0.000 description 4
CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 4
102000024920 TGF-beta family Human genes 0.000 description 4
108091020535 TGF-beta family Proteins 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
239000011324 bead Substances 0.000 description 4
150000004663 bisphosphonates Chemical class 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
229910052791 calcium Inorganic materials 0.000 description 4
239000011575 calcium Substances 0.000 description 4
239000001506 calcium phosphate Substances 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
108091006028 chimera Proteins 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
230000003247 decreasing Effects 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000009472 formulation Methods 0.000 description 4
238000001415 gene therapy Methods 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
238000001794 hormone therapy Methods 0.000 description 4
210000004962 mammalian cells Anatomy 0.000 description 4
239000003550 marker Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
238000010172 mouse model Methods 0.000 description 4
238000009806 oophorectomy Methods 0.000 description 4
239000000825 pharmaceutical preparation Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
102000004196 processed proteins & peptides Human genes 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
239000000047 product Substances 0.000 description 4
DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
230000002797 proteolythic Effects 0.000 description 4
238000007634 remodeling Methods 0.000 description 4
238000003571 reporter gene assay Methods 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
239000000523 sample Substances 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
150000003384 small molecules Chemical class 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
239000000243 solution Substances 0.000 description 4
241000894007 species Species 0.000 description 4
238000011105 stabilization Methods 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 4
239000003826 tablet Substances 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
241000701447 unidentified baculovirus Species 0.000 description 4
238000005406 washing Methods 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
OGBMKVWORPGQRR-UMXFMPSGSA-N 52232-67-4 Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 description 3
102000005606 Activins Human genes 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
210000000628 Antibody-Producing Cells Anatomy 0.000 description 3
102100015882 BMP7 Human genes 0.000 description 3
208000003432 Bone Disease Diseases 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
101700005876 FSTL3 Proteins 0.000 description 3
102100012731 FSTL3 Human genes 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
108010004250 Inhibins Proteins 0.000 description 3
ZPNFWUPYTFPOJU-LPYSRVMUSA-N Iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 3
206010022114 Injury Diseases 0.000 description 3
XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 3
235000010643 Leucaena leucocephala Nutrition 0.000 description 3
240000007472 Leucaena leucocephala Species 0.000 description 3
206010058467 Lung neoplasm malignant Diseases 0.000 description 3
229920000272 Oligonucleotide Polymers 0.000 description 3
108090000573 Osteocalcin Proteins 0.000 description 3
102000004067 Osteocalcin Human genes 0.000 description 3
229940067631 Phospholipids Drugs 0.000 description 3
229940023488 Pill Drugs 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
210000002966 Serum Anatomy 0.000 description 3
108010049264 Teriparatide Proteins 0.000 description 3
210000001685 Thyroid Gland Anatomy 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
102000000523 Type II Activin Receptors Human genes 0.000 description 3
108010041546 Type II Activin Receptors Proteins 0.000 description 3
229940046008 Vitamin D Drugs 0.000 description 3
229930003316 Vitamin D Natural products 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
238000007792 addition Methods 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000000240 adjuvant Effects 0.000 description 3
239000000556 agonist Substances 0.000 description 3
230000001580 bacterial Effects 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
102000024070 binding proteins Human genes 0.000 description 3
108091007650 binding proteins Proteins 0.000 description 3
238000006065 biodegradation reaction Methods 0.000 description 3
239000002775 capsule Substances 0.000 description 3
238000005277 cation exchange chromatography Methods 0.000 description 3
238000001246 colloidal dispersion Methods 0.000 description 3
230000000875 corresponding Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
229910003460 diamond Inorganic materials 0.000 description 3
239000010432 diamond Substances 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
239000003995 emulsifying agent Substances 0.000 description 3
230000002255 enzymatic Effects 0.000 description 3
235000019441 ethanol Nutrition 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
239000005090 green fluorescent protein Substances 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
229920000669 heparin Polymers 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
229910052588 hydroxylapatite Inorganic materials 0.000 description 3
239000000893 inhibin Substances 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000003834 intracellular Effects 0.000 description 3
238000002955 isolation Methods 0.000 description 3
GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
239000008101 lactose Substances 0.000 description 3
201000005202 lung cancer Diseases 0.000 description 3
238000005259 measurement Methods 0.000 description 3
VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 3
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
239000002245 particle Substances 0.000 description 3
230000000275 pharmacokinetic Effects 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
150000003904 phospholipids Chemical class 0.000 description 3
229920002704 polyhistidine Polymers 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000003405 preventing Effects 0.000 description 3
229920002033 ribozyme Polymers 0.000 description 3
231100000486 side effect Toxicity 0.000 description 3
230000002459 sustained Effects 0.000 description 3
230000002194 synthesizing Effects 0.000 description 3
229960005460 teriparatide Drugs 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
235000019166 vitamin D Nutrition 0.000 description 3
239000011710 vitamin D Substances 0.000 description 3
150000003710 vitamin D derivatives Chemical class 0.000 description 3
239000000080 wetting agent Substances 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
229920002395 Aptamer Polymers 0.000 description 2
241000416162 Astragalus gummifer Species 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
230000036868 Blood Concentration Effects 0.000 description 2
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 2
241000701822 Bovine papillomavirus Species 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L Calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
241000202252 Cerberus Species 0.000 description 2
229940107161 Cholesterol Drugs 0.000 description 2
229920001268 Cholestyramine Polymers 0.000 description 2
229920002676 Complementary DNA Polymers 0.000 description 2
229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 description 2
229960001334 Corticosteroids Drugs 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
108010013369 EC 3.4.21.9 Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102100009705 ENG Human genes 0.000 description 2
102000033147 ERVK-25 Human genes 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108009000074 Endochondral Ossification Proteins 0.000 description 2
108010036395 Endoglin Proteins 0.000 description 2
CXOFVDLJLONNDW-UHFFFAOYSA-N Epinat Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
108091006004 Fc-tagged proteins Proteins 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
210000004349 Growth Plate Anatomy 0.000 description 2
210000001624 Hip Anatomy 0.000 description 2
102000008100 Human Serum Albumin Human genes 0.000 description 2
108091006822 Human Serum Albumin Proteins 0.000 description 2
206010020850 Hyperthyroidism Diseases 0.000 description 2
108090000745 Immune Sera Proteins 0.000 description 2
102000018358 Immunoglobulins Human genes 0.000 description 2
108060003951 Immunoglobulins Proteins 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
241000713869 Moloney murine leukemia virus Species 0.000 description 2
241000713333 Mouse mammary tumor virus Species 0.000 description 2
210000001672 Ovary Anatomy 0.000 description 2
210000004197 Pelvis Anatomy 0.000 description 2
108091005771 Peptidases Proteins 0.000 description 2
206010035109 Pituitary-dependent Cushing's syndrome Diseases 0.000 description 2
108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
229960004063 Propylene glycol Drugs 0.000 description 2
239000004365 Protease Substances 0.000 description 2
241000724205 Rice stripe tenuivirus Species 0.000 description 2
102100007015 SERPINE1 Human genes 0.000 description 2
102100017669 SMAD2 Human genes 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
101710043164 Segment-4 Proteins 0.000 description 2
229940095743 Selective estrogen receptor modulators Drugs 0.000 description 2
RMAQACBXLXPBSY-UHFFFAOYSA-N Silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
108010007585 Smad2 Protein Proteins 0.000 description 2
102100009508 TMPRSS15 Human genes 0.000 description 2
229940116362 Tragacanth Drugs 0.000 description 2
229920001615 Tragacanth Polymers 0.000 description 2
HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 2
101700038759 VP1 Proteins 0.000 description 2
206010048049 Wrist fracture Diseases 0.000 description 2
108010023079 activin B Proteins 0.000 description 2
238000001261 affinity purification Methods 0.000 description 2
239000008272 agar Substances 0.000 description 2
235000010419 agar Nutrition 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
150000003868 ammonium compounds Chemical class 0.000 description 2
230000001195 anabolic Effects 0.000 description 2
239000003263 anabolic agent Substances 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000003160 anti-catabolic Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
239000000440 bentonite Substances 0.000 description 2
229910000278 bentonite Inorganic materials 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
239000002617 bone density conservation agent Substances 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000022159 cartilage development Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000000423 cell based assay Methods 0.000 description 2
230000001413 cellular Effects 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
239000003246 corticosteroid Substances 0.000 description 2
229960004544 cortisone Drugs 0.000 description 2
PMATZTZNYRCHOR-UHFFFAOYSA-N cyclosporine A Chemical compound CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-UHFFFAOYSA-N 0.000 description 2
230000000378 dietary Effects 0.000 description 2
230000035194 endochondral ossification Effects 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000000945 filler Substances 0.000 description 2
238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
230000002068 genetic Effects 0.000 description 2
201000003617 glucocorticoid-induced osteoporosis Diseases 0.000 description 2
239000008187 granular material Substances 0.000 description 2
230000036541 health Effects 0.000 description 2
101700005460 hemA Proteins 0.000 description 2
239000000185 hemagglutinin Substances 0.000 description 2
238000002657 hormone replacement therapy Methods 0.000 description 2
229960000890 hydrocortisone Drugs 0.000 description 2
201000002980 hyperparathyroidism Diseases 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
239000003701 inert diluent Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
230000032631 intramembranous ossification Effects 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
239000008297 liquid dosage form Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
108091022076 maltose binding proteins Proteins 0.000 description 2
239000000693 micelle Substances 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
239000012457 nonaqueous media Substances 0.000 description 2
239000003921 oil Substances 0.000 description 2
239000004006 olive oil Substances 0.000 description 2
235000008390 olive oil Nutrition 0.000 description 2
210000000056 organs Anatomy 0.000 description 2
230000001575 pathological Effects 0.000 description 2
125000001151 peptidyl group Chemical group 0.000 description 2
230000002093 peripheral Effects 0.000 description 2
230000036231 pharmacokinetics Effects 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
230000000865 phosphorylative Effects 0.000 description 2
229920000747 poly(lactic acid) polymer Polymers 0.000 description 2
108091008117 polyclonal antibodies Proteins 0.000 description 2
239000004626 polylactic acid Substances 0.000 description 2
230000001323 posttranslational Effects 0.000 description 2
229960004618 prednisone Drugs 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000000750 progressive Effects 0.000 description 2
230000000644 propagated Effects 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
239000002510 pyrogen Substances 0.000 description 2
238000003259 recombinant expression Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000000333 selective estrogen receptor modulator Substances 0.000 description 2
238000002864 sequence alignment Methods 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
238000003530 single readout Methods 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
230000004936 stimulating Effects 0.000 description 2
239000000375 suspending agent Substances 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
239000005495 thyroid hormone Substances 0.000 description 2
229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 description 2
235000010487 tragacanth Nutrition 0.000 description 2
239000000196 tragacanth Substances 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
230000001131 transforming Effects 0.000 description 2
230000001052 transient Effects 0.000 description 2
102000035402 transmembrane proteins Human genes 0.000 description 2
108091005683 transmembrane proteins Proteins 0.000 description 2
229940078499 tricalcium phosphate Drugs 0.000 description 2
229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
235000019731 tricalcium phosphate Nutrition 0.000 description 2
239000011778 trisodium citrate Substances 0.000 description 2
230000002792 vascular Effects 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
238000011100 viral filtration Methods 0.000 description 2
230000003612 virological Effects 0.000 description 2
NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17 Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
OHJKXVLJWUPWQG-IUYNYSEKSA-J (4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate Chemical compound O[C@@H]1C(NS([O-])(=O)=O)C(O)O[C@H](COS([O-])(=O)=O)C1O[C@H]1C(OS([O-])(=O)=O)[C@@H](O)C(O)C(C([O-])=O)O1 OHJKXVLJWUPWQG-IUYNYSEKSA-J 0.000 description 1
ZAKBPRIDLSBYQQ-VHSXEESVSA-N 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OC[C@@H](O)CO ZAKBPRIDLSBYQQ-VHSXEESVSA-N 0.000 description 1
NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
229940058015 1,3-butylene glycol Drugs 0.000 description 1
JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N 2-stearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-Phosphoglyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 description 1
101710026724 ACVR1B Proteins 0.000 description 1
102100000003 ACVR1B Human genes 0.000 description 1
101710026725 ACVR1C Proteins 0.000 description 1
102100000004 ACVR1C Human genes 0.000 description 1
102100001249 ALB Human genes 0.000 description 1
101710027066 ALB Proteins 0.000 description 1
229940070021 ANABOLIC STEROIDS Drugs 0.000 description 1
229940069428 ANTACIDS Drugs 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
206010059837 Adhesion Diseases 0.000 description 1
210000004100 Adrenal Glands Anatomy 0.000 description 1
XJKJWTWGDGIQRH-BFIDDRIFSA-N Alginic acid Chemical compound O1[C@@H](C(O)=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](C)[C@@H](O)[C@H]1O XJKJWTWGDGIQRH-BFIDDRIFSA-N 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
241000269328 Amphibia Species 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
210000001737 Ankle Joint Anatomy 0.000 description 1
208000000103 Anorexia Nervosa Diseases 0.000 description 1
235000017060 Arachis glabrata Nutrition 0.000 description 1
240000005781 Arachis hypogaea Species 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
235000018262 Arachis monticola Nutrition 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
206010003246 Arthritis Diseases 0.000 description 1
229960001230 Asparagine Drugs 0.000 description 1
229960005261 Aspartic Acid Drugs 0.000 description 1
235000010751 Asperula odorata Nutrition 0.000 description 1
206010003816 Autoimmune disease Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000714235 Avian retrovirus Species 0.000 description 1
101710002767 BACOVA_02645 Proteins 0.000 description 1
102100007311 BMP10 Human genes 0.000 description 1
101700058635 BMP10 Proteins 0.000 description 1
101700060441 BMP7 Proteins 0.000 description 1
HNYOPLTXPVRDBG-UHFFFAOYSA-N Barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
230000036912 Bioavailability Effects 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
210000004204 Blood Vessels Anatomy 0.000 description 1
210000001185 Bone Marrow Anatomy 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
210000000481 Breast Anatomy 0.000 description 1
206010006313 Breast tenderness Diseases 0.000 description 1
101710010587 CASP13 Proteins 0.000 description 1
102100016596 CER1 Human genes 0.000 description 1
101700009240 CER1 Proteins 0.000 description 1
229960003563 Calcium Carbonate Drugs 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
210000004671 Cell-Free System Anatomy 0.000 description 1
OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
229960004926 Chlorobutanol Drugs 0.000 description 1
210000001612 Chondrocytes Anatomy 0.000 description 1
210000000349 Chromosomes Anatomy 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
229940097479 Colestid Drugs 0.000 description 1
GMRWGQCZJGVHKL-UHFFFAOYSA-N Colestipol Chemical compound ClCC1CO1.NCCNCCNCCNCCN GMRWGQCZJGVHKL-UHFFFAOYSA-N 0.000 description 1
229920002911 Colestipol Polymers 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
210000002808 Connective Tissue Anatomy 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
229940119017 Cyclosporine Drugs 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
210000000805 Cytoplasm Anatomy 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
ZAHDXEIQWWLQQL-IHRRRGAJSA-N Deoxypyridinoline Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(O)=C(C[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 ZAHDXEIQWWLQQL-IHRRRGAJSA-N 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
NEFBYIFKOOEVPA-UHFFFAOYSA-K Dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
235000019739 Dicalciumphosphate Nutrition 0.000 description 1
229940064790 Dilantin Drugs 0.000 description 1
KILNVBDSWZSGLL-KXQOOQHDSA-N Dipalmitoylphosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
206010014733 Endometrial cancer Diseases 0.000 description 1
210000004494 Erythroblasts Anatomy 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N Ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
206010063560 Excessive granulation tissue Diseases 0.000 description 1
210000002744 Extracellular Matrix Anatomy 0.000 description 1
210000003414 Extremities Anatomy 0.000 description 1
101710003435 FCGRT Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
210000002683 Foot Anatomy 0.000 description 1
210000000610 Foot Bones Anatomy 0.000 description 1
206010016970 Foot fracture Diseases 0.000 description 1
102100011343 GLB1 Human genes 0.000 description 1
101700014779 GLB1 Proteins 0.000 description 1
102100014497 GOLPH3 Human genes 0.000 description 1
101710008339 GOLPH3 Proteins 0.000 description 1
240000005071 Galium odoratum Species 0.000 description 1
235000008526 Galium odoratum Nutrition 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
229960002989 Glutamic Acid Drugs 0.000 description 1
RWSXRVCMGQZWBV-WDSKDSINSA-N Glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
229960003180 Glutathione Drugs 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
XLXSAKCOAKORKW-UHFFFAOYSA-N Gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 1
108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
229960002913 Goserelin Drugs 0.000 description 1
210000001126 Granulation Tissue Anatomy 0.000 description 1
206010018852 Haematoma Diseases 0.000 description 1
206010018987 Haemorrhage Diseases 0.000 description 1
210000004247 Hand Anatomy 0.000 description 1
229960002897 Heparin Drugs 0.000 description 1
ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
229960002591 Hydroxyproline Drugs 0.000 description 1
102100006950 INHA Human genes 0.000 description 1
229960000310 ISOLEUCINE Drugs 0.000 description 1
102000009490 IgG Receptors Human genes 0.000 description 1
108010073807 IgG Receptors Proteins 0.000 description 1
210000000987 Immune System Anatomy 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
210000004969 Inflammatory Cells Anatomy 0.000 description 1
229920002459 Intron Polymers 0.000 description 1
208000001083 Kidney Disease Diseases 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-Methionine Natural products CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
101700037605 LIF Proteins 0.000 description 1
102100011646 LIF Human genes 0.000 description 1
229940067606 Lecithin Drugs 0.000 description 1
206010024324 Leukaemias Diseases 0.000 description 1
210000004185 Liver Anatomy 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
108060001084 Luciferase family Proteins 0.000 description 1
210000004072 Lung Anatomy 0.000 description 1
229940087857 Lupron Drugs 0.000 description 1
210000004698 Lymphocytes Anatomy 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102100000541 MARK2 Human genes 0.000 description 1
101700064507 MARK2 Proteins 0.000 description 1
101700072011 MSX2 Proteins 0.000 description 1
102100015262 MYC Human genes 0.000 description 1
241000282567 Macaca fascicularis Species 0.000 description 1
229920002521 Macromolecule Polymers 0.000 description 1
206010025476 Malabsorption Diseases 0.000 description 1
208000003393 Mammary Paget's Disease Diseases 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010027304 Menopausal symptom Diseases 0.000 description 1
206010027336 Menstruation delayed Diseases 0.000 description 1
210000002901 Mesenchymal Stem Cells Anatomy 0.000 description 1
210000003716 Mesoderm Anatomy 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
229940051866 Mouthwash Drugs 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-ACETYL-D-GALACTOSAMINE Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-Acetylglucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
229950006780 N-Acetylglucosamine Drugs 0.000 description 1
101700062818 NP Proteins 0.000 description 1
229940100662 Nasal Drops Drugs 0.000 description 1
229940063121 Neoral Drugs 0.000 description 1
108010061543 Neutralizing Antibodies Proteins 0.000 description 1
206010030247 Oestrogen deficiency Diseases 0.000 description 1
210000003463 Organelles Anatomy 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000010191 Osteitis Deformans Diseases 0.000 description 1
206010049088 Osteopenia Diseases 0.000 description 1
101710043203 P23p89 Proteins 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
210000003460 Periosteum Anatomy 0.000 description 1
229960005190 Phenylalanine Drugs 0.000 description 1
229960002036 Phenytoin Drugs 0.000 description 1
UNJJBGNPUUVVFQ-ZJUUUORDSA-N Phosphatidylserine Chemical compound CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O UNJJBGNPUUVVFQ-ZJUUUORDSA-N 0.000 description 1
108091000081 Phosphotransferases Proteins 0.000 description 1
210000003635 Pituitary Gland Anatomy 0.000 description 1
210000002381 Plasma Anatomy 0.000 description 1
230000037289 Plasma half life Effects 0.000 description 1
230000037240 Plasma half-life Effects 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
239000004698 Polyethylene (PE) Substances 0.000 description 1
108010050808 Procollagen Proteins 0.000 description 1
210000002307 Prostate Anatomy 0.000 description 1
102000001253 Protein Kinases Human genes 0.000 description 1
108010078762 Protein Precursors Proteins 0.000 description 1
102000014961 Protein Precursors Human genes 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
LCYXYLLJXMAEMT-SAXRGWBVSA-N Pyridinoline Chemical compound OC(=O)[C@@H](N)CCC1=C[N+](C[C@H](O)CC[C@H](N)C([O-])=O)=CC(O)=C1C[C@H](N)C(O)=O LCYXYLLJXMAEMT-SAXRGWBVSA-N 0.000 description 1
229940073095 Questran Drugs 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108010033725 Recombinant Proteins Proteins 0.000 description 1
102000007312 Recombinant Proteins Human genes 0.000 description 1
230000036045 Renal clearance Effects 0.000 description 1
206010062237 Renal impairment Diseases 0.000 description 1
229920000970 Repeated sequence (DNA) Polymers 0.000 description 1
229940061969 Rheumatrex Drugs 0.000 description 1
208000010487 Rib Fractures Diseases 0.000 description 1
229940063122 Sandimmune Drugs 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
108010070144 Single-Chain Antibodies Proteins 0.000 description 1
102000005632 Single-Chain Antibodies Human genes 0.000 description 1
108010003723 Single-Domain Antibodies Proteins 0.000 description 1
210000003625 Skull Anatomy 0.000 description 1
102000007374 Smad Proteins Human genes 0.000 description 1
108010007945 Smad Proteins Proteins 0.000 description 1
108020004459 Small Interfering RNA Proteins 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
240000001016 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
229940075582 Sorbic Acid Drugs 0.000 description 1
JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical class OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
WWUZIQQURGPMPG-KRWOKUGFSA-N Sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
210000000952 Spleen Anatomy 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
210000002784 Stomach Anatomy 0.000 description 1
229940014598 TAC Drugs 0.000 description 1
OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
229960002180 Tetracycline Drugs 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
BSYVTEYKTMYBMK-UHFFFAOYSA-N Tetrahydro-2-furanmethanol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
229940094937 Thioredoxin Drugs 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
ITMCEJHCFYSIIV-UHFFFAOYSA-N Trifluoromethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
102000002138 Type I Activin Receptors Human genes 0.000 description 1
108010015920 Type I Activin Receptors Proteins 0.000 description 1
210000002700 Urine Anatomy 0.000 description 1
210000004291 Uterus Anatomy 0.000 description 1
208000007089 Vaccinia Diseases 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
206010046910 Vaginal haemorrhage Diseases 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
210000002845 Virion Anatomy 0.000 description 1
229940046010 Vitamin K Drugs 0.000 description 1
229930003448 Vitamin K Natural products 0.000 description 1
229940019697 Vitamin K containing hemostatics Drugs 0.000 description 1
210000000707 Wrist Anatomy 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
229940033942 Zoladex Drugs 0.000 description 1
239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
HGMSJMJPXGGEBP-UHFFFAOYSA-N [4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylazanium Chemical compound C1=CC(CC)=CC=C1C(C)CCC1=CC=C([N+](C)(C)C)C=C1 HGMSJMJPXGGEBP-UHFFFAOYSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
230000011759 adipose tissue development Effects 0.000 description 1
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
SMYKVLBUSSNXMV-UHFFFAOYSA-J aluminum;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-J 0.000 description 1
125000003368 amide group Chemical group 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
239000003159 antacid agent Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000001458 anti-acid Effects 0.000 description 1
230000002429 anti-coagulation Effects 0.000 description 1
230000000111 anti-oxidant Effects 0.000 description 1
230000002788 anti-peptide Effects 0.000 description 1
230000000123 anti-resoprtive Effects 0.000 description 1
230000000573 anti-seizure Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000000823 artificial membrane Substances 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
108010003152 bacteriophage T7 RNA polymerase Proteins 0.000 description 1
230000003542 behavioural Effects 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
229960004217 benzyl alcohol Drugs 0.000 description 1
229960002903 benzyl benzoate Drugs 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
230000001588 bifunctional Effects 0.000 description 1
230000000975 bioactive Effects 0.000 description 1
230000035514 bioavailability Effects 0.000 description 1
239000003462 bioceramic Substances 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
230000003115 biocidal Effects 0.000 description 1
239000005312 bioglass Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000004271 bone marrow stromal cells Anatomy 0.000 description 1
230000004097 bone metabolism Effects 0.000 description 1
239000004067 bulking agent Substances 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
210000000459 calcaneus Anatomy 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
238000005251 capillar electrophoresis Methods 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
230000001925 catabolic Effects 0.000 description 1
230000035569 catabolism Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000003197 catalytic Effects 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
101700018328 ccdB Proteins 0.000 description 1
239000006143 cell culture media Substances 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
230000001684 chronic Effects 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
239000004927 clay Substances 0.000 description 1
229910052570 clay Inorganic materials 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
229910052803 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
238000005037 combinatorial chemistry Methods 0.000 description 1
238000002742 combinatorial mutagenesis Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000023298 conjugation with cellular fusion Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
235000005824 corn Nutrition 0.000 description 1
238000002316 cosmetic surgery Methods 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
230000001808 coupling Effects 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
210000004748 cultured cells Anatomy 0.000 description 1
230000001472 cytotoxic Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000004059 degradation Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000593 degrading Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000003111 delayed Effects 0.000 description 1
230000002939 deleterious Effects 0.000 description 1
238000005115 demineralization Methods 0.000 description 1
230000002328 demineralizing Effects 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
230000001809 detectable Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
229940038472 dicalcium phosphate Drugs 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000008298 dragée Substances 0.000 description 1
238000007877 drug screening Methods 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
238000004043 dyeing Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
101710019483 ebgA Proteins 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002257 embryonic structures Anatomy 0.000 description 1
201000009273 endometriosis Diseases 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
210000002919 epithelial cells Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
229940093499 ethyl acetate Drugs 0.000 description 1
CQDGTJPVBWZJAZ-UHFFFAOYSA-M ethyl carbonate Chemical compound CCOC([O-])=O CQDGTJPVBWZJAZ-UHFFFAOYSA-M 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
230000005713 exacerbation Effects 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000002875 fluorescence polarization Methods 0.000 description 1
108091006031 fluorescent proteins Proteins 0.000 description 1
102000034387 fluorescent proteins Human genes 0.000 description 1
101710034616 gVIII-1 Proteins 0.000 description 1
201000003010 gallbladder disease Diseases 0.000 description 1
150000002270 gangliosides Chemical class 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
150000004676 glycans Polymers 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
230000002414 glycolytic Effects 0.000 description 1
150000002338 glycosides Chemical class 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
230000009067 heart development Effects 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
239000003906 humectant Substances 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
230000003100 immobilizing Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
230000002757 inflammatory Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
108010019691 inhibin beta A subunit Proteins 0.000 description 1
108010032856 inhibin-alpha subunit Proteins 0.000 description 1
238000003780 insertion Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
125000001909 leucine group Chemical class [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
RGLRXNKKBLIBQS-XNHQSDQCSA-N leuprolide acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 RGLRXNKKBLIBQS-XNHQSDQCSA-N 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
201000007270 liver cancer Diseases 0.000 description 1
201000009673 liver disease Diseases 0.000 description 1
238000011068 load Methods 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000004777 loss-of-function mutation Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000003670 luciferase enzyme activity assay Methods 0.000 description 1
239000006166 lysate Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
230000009245 menopause Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002741 methionine derivatives Chemical group 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
102000035365 modified proteins Human genes 0.000 description 1
108091005569 modified proteins Proteins 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
201000008895 mood disease Diseases 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
201000009251 multiple myeloma Diseases 0.000 description 1
230000037257 muscle growth Effects 0.000 description 1
101700045377 mvp1 Proteins 0.000 description 1
239000002088 nanocapsule Substances 0.000 description 1
239000007923 nasal drop Substances 0.000 description 1
239000005445 natural product Substances 0.000 description 1
229930014626 natural products Natural products 0.000 description 1
230000004766 neurogenesis Effects 0.000 description 1
210000002569 neurons Anatomy 0.000 description 1
230000001264 neutralization Effects 0.000 description 1
230000003472 neutralizing Effects 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
230000003287 optical Effects 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
150000002895 organic esters Chemical class 0.000 description 1
230000001009 osteoporotic Effects 0.000 description 1
210000004663 osteoprogenitor cell Anatomy 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
230000000737 periodic Effects 0.000 description 1
239000000546 pharmaceutic aid Substances 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
101700061325 pho-5 Proteins 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
125000001095 phosphatidyl group Chemical group 0.000 description 1
150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000000902 placebo Substances 0.000 description 1
230000003169 placental Effects 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
150000004804 polysaccharides Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
230000002335 preservative Effects 0.000 description 1
230000003449 preventive Effects 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
125000001235 proline group Chemical group [H]N1[C@@](C(=O)[*])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000005215 recombination Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000007261 regionalization Effects 0.000 description 1
238000002271 resection Methods 0.000 description 1
108091007521 restriction endonucleases Proteins 0.000 description 1
201000009410 rhabdomyosarcoma Diseases 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
125000003616 serine group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
238000004904 shortening Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
230000022379 skeletal muscle tissue development Effects 0.000 description 1
230000012488 skeletal system development Effects 0.000 description 1
201000000849 skin cancer Diseases 0.000 description 1
230000000391 smoking Effects 0.000 description 1
239000001187 sodium carbonate Substances 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000011775 sodium fluoride Substances 0.000 description 1
235000013024 sodium fluoride Nutrition 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007909 solid dosage form Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
150000003408 sphingolipids Chemical class 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
159000000008 strontium salts Chemical class 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
230000004083 survival Effects 0.000 description 1
230000005700 syncytium formation by plasma membrane fusion Effects 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000012085 test solution Substances 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
102000002933 thioredoxin family Human genes 0.000 description 1
108060008226 thioredoxin family Proteins 0.000 description 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N trans-L-hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
238000003160 two-hybrid assay Methods 0.000 description 1
238000010396 two-hybrid screening Methods 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
239000004474 valine Substances 0.000 description 1
229960004295 valine Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
235000019168 vitamin K Nutrition 0.000 description 1
239000011712 vitamin K Substances 0.000 description 1
150000003721 vitamin K derivatives Chemical class 0.000 description 1
238000001262 western blot Methods 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1

JP2008542460A 2005-11-23 2006-11-22 アクチビン−ＡｃｔＲＩＩａアンタゴニストおよび骨成長を促進するための使用 Active JP5261187B2 (ja)